What is the Alabama 369 form?
The Alabama 369 form, also known as the Pharmacy Prior Authorization Request Form, is used to request prior approval from Alabama Medicaid for specific medications. This form ensures that prescribed treatments meet the necessary criteria set by the Alabama Medicaid Agency before being dispensed to patients.
Who needs to fill out the Alabama 369 form?
The prescriber, who is often a healthcare provider such as a doctor or nurse practitioner, needs to complete the form. The information provided will help justify the medical necessity of the requested medication for the patient.
What information is required on the form?
The form collects both patient and prescriber information, including names, Medicaid numbers, and contact details. It also requires details about the requested medication, its strength, quantity, and the diagnosis codes (ICD-9 or ICD-10) related to the patient's condition.
Can the Alabama 369 form be used for medication renewals?
Yes, the form has options for initial requests as well as renewals. It allows healthcare providers to indicate whether they are requesting a refill for a patient’s ongoing therapy or if it is a new treatment.
What if the medication requested is a brand name drug that has a generic equivalent?
If the requested medication is a brand name drug with a generic equivalent, the prescriber must submit the FDA MedWatch Form 3500 along with the Alabama 369 form. This step is crucial for compliance with Medicaid guidelines.
Where should the completed Alabama 369 form be sent?
The completed form can be faxed to (800) 748-0116 or mailed to P.O. Box 3210, Auburn, AL 36823-3210. Both methods are accepted by Health Information Designs, the entity that processes these requests for Alabama Medicaid.
How long does it take to receive a decision on the request?
Decisions typically occur within 24 to 48 hours after the form is submitted. However, additional information may be required, which could extend this timeframe.
What happens if the request is denied?
If Alabama Medicaid denies the prior authorization request, the prescriber will receive notification detailing the reasons. The provider can then either appeal the decision or consider alternative treatment options for the patient.
Are there special considerations for pediatric patients?
Yes, for children under the age of 6 receiving antipsychotic agents, monitoring protocols must be followed as per the guidelines on the Alabama Medicaid website. It’s essential to ensure that prescribed treatments align with specific protocols for this age group.